5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6369076B1 · kind B1 · utility
2Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2000 |
| Grant date | Apr 9, 2002 |
| Priority date | — |
| Expiry date | Oct 25, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 5-benzyl-octahydroindoles and 6-benzyl-decahydroquinolines substituted in the 1-position are effective as NMDA NR2B antagonists useful for relieving pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.